Abstract
The prokinetic effects of erythromycin, a macrolide antibiotic, on the gastrointestinal tract as a motilin receptor agonist and its potential value for the treatment of gastrointestinal motility disorders have recently attracted interest. The effects of erythromycin on the clinical symptoms and gastrointestinal motility of patients with chronic idiopathic pseudo-obstruction have not been investigated extersively. We presented a case of chronic idiopathic intestinal pseudo-obstruction, in a 67-year-old man in whom oral erythromycin (900 mg/day) dramatically improved postprandial abdominal distention, nausea, and vomiting. Other agents with prokinetic effects on intestinal motility, i.e., cisapride, domperidone, metoclopramide, and trimebutine maleate did not have a favorable effect. Gastric emptying, measured by the sulfamethizole method; and intestinal transit, evaluated using radio-opaque markers, were markedly improved by treatment with erythromycin. Our experience suggests that the prokinetic effects of erythromycin may be of therapeutic value in chronic idiopathic intestinal pseudo-obstruction.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Coleman LJ, Camilleri M. Chronic intestinal pseudo-obstruction: Diagnosis and treatment. Mayo Clin Proc 1989;64:60–70.
Camilleri M, Malagelada JR, Abell T, et al. Effects of 6 weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction. Gastroenterology 1989;96:704–712.
O'Dorisio TM, Thomas FB, Mekhjian HS. Erythromycin exerts a prokinetic effect in patients with chronic idiopathic intestinal pseudoobstruction. Gastroenterology 1989;99:A375.
Berger SA, Keshavarizan A, DeMeo MT, et al. Erythromycin in chronic intestinal pseudo-obstruction. J Clin Gastroenterol 1990;12:363.
Verne GN, Eaker EY, Hardy E, et al. Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction. Dig Dis Sci 1995;40:1892–1901.
Asada T, Murakami M, Sato Y, et al. Sulfamethizole capsule method; a new method for assessing gastric emptying of solids. Dig Dis Sci 1994;39:2056–2061.
Nishibayashi H, Kanayama S, Shinomura Y, et al. Influence of interferon-α treatment on gastric emptying in patients with chronic hepatitis C (abstract). Gastroenterology 1995;108:A657.
Satake K, Hongo M, Ujiie H, et al. The effect of cisapride on intestinal transit (in Japanese with English abstract). Nippon Heikatsukin Gakkai Zasshi (Jpn J Smooth Muscle Res) 1988;24:55–60.
Janssens J, Vantrappen G, Urbain JL, et al. The motilin agonist erythromycin normalizes impaired gastric emptying in diabetic gastroparesis. Gastroenterology 1989;96:A237.
Pilot MA, Qin YY. Macrolides and gastrointestinal motility. J Antimicrob Chemother 1988;22:201–206.
Tack J, Janssens J, Vantrappen G, et al. Effect of erythromycin on gastric motility in controls and in diabetic gastroparesis. Gastroenterology 1992;103:72–79.
Sarna SK, Soergel KH, Koch TR, et al. Gastrointestinal motor effects of erythromycin in humans. Gastroenterology 1991;101:1488–1496.
Tomomasa T, Kuroume T, Arai H, et al. Erythromycin induces migrating motor complex in human gastrointestinal tract. Dig Dis Sci 1986;31:157–161.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Minami, T., Nishibayashi, H., Shinomura, Y. et al. Effects of erythromycin in chronic idiopathic intestinal pseudo-obstruction. J Gastroenterol 31, 855–859 (1996). https://doi.org/10.1007/BF02358615
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02358615